About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Texas | 750 Studies

Clinical Trials Ovarian CancerTexas

Ovarian Cancer Clinical Trials in Texas

Find 750 clinical trials for ovarian cancer near Texas. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 341-360 of 750 trials

CompletedClinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer PatientsMulticenter, open-label, randomized, controlled phase III clinical trial to evaluate the activity and safety of PM01183 versus PLD or topotecan as control arm in patients with…NCT02421588·Peoria, Arizona and 27 others CompletedA Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsThis is an open-label, Phase I, dose-escalation study to determine the recommended Phase 2 dose (RPTD), maximum tolerated dose (MTD), and evaluate the safety and pharmacokinetic…NCT02955251·Scottsdale, Arizona and 14 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownDose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-4630 monotherapy in adult…NCT03634982·Scottsdale, Arizona and 11 others

Active not recruitingJuice Plus+ and Juice Plus+ Complete in Ovarian CancerThe goal of this clinical research study is to see if ovarian cancer patients who add Juice PLus+ and Juice Plus+ Complete to their diets have better outcomes when compared to…NCT01439659·Houston, Texas

CompletedDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerRATIONALE: Taking part in a clinical trial may help children with cancer receive more effective treatment.NCT00002485·Sacramento, California and 30 others

Active not recruitingVeliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal CancerThis phase I/II trial studies the side effects and best dose of veliparib and topotecan hydrochloride and to see how well they work in treating patients with solid tumors, ovarian…NCT01012817·Phoenix, Arizona and 14 others

CompletedPilot Study of Durvalumab and Vigil in Advanced Women's CancersIn this study, the researchers want to learn more about Vigil and durvalumab in advanced women's cancers: 1) how much of Vigil in combination with durvalumab (MEDI4736) can be…NCT02725489·Dallas, Texas

RecruitingFiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCThe goal of this clinical study is to learn more about the study drug, TUB-040, including its safety, tolerability, pharmacokinetics, and preliminary efficacy, and to determine…NCT06303505·Birmingham, Alabama and 20 others

CompletedA Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)The Purpose of this study is to investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of hSTC810 monotherapy in participants with advanced solid tumors.NCT05231746·New Haven, Connecticut and 4 others

SuspendedFirst-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.The study consists of two parts based on the administration of single-agent GRN-300 or in combination with paclitaxel.NCT04711161·Houston, Texas

Completedp53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246The purpose of this study is to make a preliminary assessment of the efficacy of a combined APR-246 and carboplatin/PLD chemotherapy regimen, compared with carboplatin/PLD…NCT02098343·Los Angeles, California and 54 others

TerminatedPRO1107 in Patients With Advanced Solid TumorsThis is a global, open-label, multicenter Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics (PK), and antitumor activity of GEN1107 (PRO1107) in participants…NCT06171789·Scottsdale, Arizona and 6 others

CompletedAttitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)Objectives: \- To evaluate the attitudes and opinions of women undergoing genetic counseling for hereditary breast and ovarian cancer syndrome, both before and after testing, in…NCT00829959·Houston, Texas

TerminatedStudy of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian CancerPegylated liposomal doxorubicin (PLD), a type of chemotherapy, is a standard treatment option for patients with platinum-resistant ovarian cancer.NCT05261490·Santa Monica, California and 17 others

UnknownENB003 Plus Pembrolizumab Phase 1b/2a in Solid TumorsFirst-in Human study evaluating the safety, tolerability and efficacy of ENB003 in combination with Pembrolizumab in solid tumors. The study is separated into two parts.NCT04205227·Los Angeles, California and 4 others

CompletedPhase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer PatientsThis is a single-center, randomized, single-blinded, three-arm phase Ib study of the folate binding protein vaccines E39 and J65.NCT02019524·Houston, Texas

UnknownStudy of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerT cell activating therapy DPX-Survivac, low dose oral cyclophosphamide, and IDO1 inhibitor epacadostat will be tested together for the first time in patients with recurrent…NCT02785250·Palo Alto, California and 8 others

CompletedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03662204·Phoenix, Arizona and 118 others

TerminatedAutologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal AdenocarcinomaThis phase II trial studies how well autologous tumor infiltrating lymphocytes MDA-TIL works in treating patients with ovarian cancer, colorectal cancer, or pancreatic ductal…NCT03610490·Houston, Texas

CompletedTRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerThe purpose of this study is to determine if treatment with paclitaxel plus AMG 386 is superior to paclitaxel plus placebo in women with recurrent partially platinum sensitive or…NCT01204749·Phoenix, Arizona and 224 others

PreviousPage 18 of 38Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia